Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids

• Status: Completed
• Trial end date: 2017-06-29

Summary

This is a 2-year study to evaluate the effect of denosumab versus risedronate in adults with glucocorticoid-induced osteoporosis.

• Phase: Phase 3

Details

• Lead Sponsor: Amgen
• Treatments: Denosumab; Etidronic Acid; Glucocorticoids; Risedronate Sodium